WHO has launched a new resource tool on alcohol taxation and pricing policies. The book has been developed under a Memorandum of Understanding between ThaiHealth and WHO as a part of a broader effort by WHO to develop technical tools and resource materials in support of implementation of the global strategy to reduce the harmful use of alcohol. The intentions of the resource tool is to enhance knowledge and competence relating to taxation and pricing policies among public health professionals and alcohol-control policy advocates.
The World Health Organization (WHO) Department of Mental Health and Substance Abuse organized, for the first time, a global Forum on alcohol, drugs and addictive behaviours (FADAB) with a primary goal to enhance public health actions in these areas by strengthening partnerships and collaboration among public health oriented organizations, networks and institutions in the era of Sustainable Development Goals 2030 (SDG 2030).
More than 200 participants attended forum which took place from 26 to 28 June 2017 at WHO headquarters in Geneva, Switzerland.
Delegates from 194 Member States reached important conclusions pertaining to substance abuse at the 70th session of the World Health Assembly held in Geneva Switzerland from 21 to 31 May 2017. Consensus were reached on the decision "Public health dimension of the world drug problem" and on the resolution "Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018", in which the updated Appendix 3 to the global action plan for the prevention and control of noncommunicable diseases 2013–2020 was endorsed.
Strengthening collaboration with UNODC
WHO and the United Nations Office on Drugs and Crime (UNODC) have made official plans for strengthened collaboration on the public health issues relating to drug use around the world. The Memorandum of Understanding signed builds on the ongoing collaboration between the two UN entities, already intensive in the areas of drug dependence treatment and care. Areas for further joint work will include prevention of drug use and drug use disorders, improving access to medicines under international control, addressing the challenges of new psychoactive substances (NPS) and monitoring drug use and its health and social consequences.
1.7 bedsper 100 000 population are available for the treatment of alcohol and drug use disordersBeds for the treatment of alcohol and drug use disorders
The Global Information System on Alcohol and Health
The Global Information System on Alcohol and Health (GISAH) provides easy and rapid access to a wide range of alcohol-related health indicators. It is an essential tool for assessing and monitoring the health situation and trends related to alcohol consumption, alcohol-related harm, and policy responses in countries.
This web site contains information pertaining to psychoactive substance use and abuse, and also information about the World Health Organization's projects and activities in the areas of substance use and substance dependence.
WHO is the only agency dealing with all psychoactive substances, regardless of their legal status. WHO’s mandate in the area of psychoactive substance use includes:
- Prevention and reduction of the negative health and social consequences of psychoactive substance use;
- Reduction of the demand for non-medical use of psychoactive substances;
- Assessment of psychoactive substances so as to advise the United Nations with regard to their regulatory control.
Since its founding in 1948, WHO has played a leading role in supporting countries to prevent and reduce the problems due to psychoactive substance use, and in recommending which psychoactive substances should be regulated. In 2000, the Department of Substance Abuse was merged with the Department of Mental Health to form the Department of Mental Health and Substance Abuse, reflecting the many common approaches of management of mental health and substance use disorders.